RSRoza Seisebayeva

Roza Seisebayeva

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Roza Seisebayeva has a total of 24 co-authors. Here are the top co-authors by number of shared publications:


Latest Publications

  • Open Access

    Fallopia convolvulus (L.) Á. Löve: Review of traditional use, phytochemistry and pharmacology

    by Zhanbota Akmuratkyzy, Aknur Turgumbayeva, Marzhan Kulbayeva, Amirkan Azembayev, Zhanar Nurgaliyeva, Roza Seisebayeva, Gulshat Kulniyazova, Kulyash Jaxalykova, Bekturgan Karin, Zhanar Aubakirova, et al.

    Fallopia convolvulus (L.) Á. Löve, a widely distributed species of the Polygonaceae family, has long been valued in traditional medicine for its diverse therapeutic applications. This review investigates its phytochemical composition, traditional uses, and pharmacological potential, placing the plant in the broader context of natural product research. Bioactive compounds such as flavonoids, anthraquinones, steroids, and phenolic acids, which exhibit antioxidant, anti-inflammatory, antimicrobial, and anticancer activities, are compiled and analyzed. Modern techniques have identified novel compounds like falloconvolin A and B, as well as compounds with estrogenic and neuroprotective properties. To support this analysis, information was sourced from ethnobotanical, phytochemical, pharmacological, and clinical studies, utilizing databases like PubMed, Science Direct, and ResearchGate. This comprehensive analysis underscores the importance of further research to elucidate the mechanisms of action of its bioactive constituents and to explore its potential for pharmaceutical innovation. Fallopia convolvulus represents a promising, sustainable resource for developing novel therapeutic agents, bridging traditional medicine with modern science.


  • Open Access

    The Role of Perinatal Complications in Neurodevelopmental Outcomes of ART-Conceived Children: Prognostic Model for Brain Immaturity

    by Sevara Ilmuratova, Vyacheslav Lokshin, Zhanar Nurgaliyeva, Kаnatzhan Kеmelbekov, Gulshat Kulniyazova, Bibigul Abdykalykova, Roza Seisebayeva, Karlygash Zhubanysheva, Gulmira Altynbayeva, Gulnar Mukhambetova, et al.

    Background/Objectives: Since the first successful birth following assisted reproductive technologies (ART) several decades ago, the global population of ART-conceived children has surpassed 13 million, with over 40,000 born in Kazakhstan. Despite this growth, questions remain about their long-term neurological outcomes, with existing studies reporting inconsistent findings. This study aimed to assess psychomotor development and the prevalence of nervous system pathologies among ART-conceived children in Kazakhstan and to develop a prognostic model for identifying pathological neurodevelopmental conditions. Methods: We studied 252 children (120 conceived via ART and 132 controls) using clinical examination and medical history data. Brain immaturity predictors were identified by univariate and multivariate logistic regression. Results: ART-conceived children exhibited a higher incidence of neurosonographic signs of brain structure immaturity. However, multivariate analysis indicated that ART itself was not an independent risk factor. Instead, perinatal complications—including prematurity, multiple pregnancy, low birth weight, asphyxia, and intrauterine infections—explained the observed differences. The prognostic model highlighted prematurity and preconceptional progesterone therapy as significant predictors. Overall neurological development did not differ significantly between the groups. Conclusions: These findings underscore the importance of early identification of perinatal risk factors and targeted preventive interventions to mitigate adverse neurodevelopmental outcomes in ART-conceived children.